Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine Frank Dolan May 8, 2025
Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023 Frank Dolan May 8, 2025
FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership Frank Dolan May 8, 2025
Marea Therapeutics Advances to Phase 2b: Promising Results from New Biomarker Data for Cardiovascular Drug Frank Dolan May 7, 2025
Vinay Prasad’s FDA Leadership: A Turning Point for Cell and Gene Therapy Stocks? Frank Dolan May 7, 2025
Revolutionizing US Drug Pricing: Bipartisan Efforts to Align with Global Rates Gain Momentum Frank Dolan May 6, 2025
Singapore Biotech Secures $45M for Groundbreaking Gene Therapy in Heart Disorders: Eyes European Market Expansion Frank Dolan May 6, 2025
BioNTech Assures Investors: RFK Jr.’s Vaccine Proposal Has No Immediate Threat to COVID-19 Franchise Frank Dolan May 5, 2025
Promising Breakthroughs: First Human Data on In Vivo CAR-T Therapy from China Biotech Trials Frank Dolan May 5, 2025
Amgen’s Biosimilar Surge: $150 Million in Stelara Sales and a 35% Revenue Boost in Q1 2025 Frank Dolan May 3, 2025
White House Budget Proposal: Major Cuts to NIH and CDC Signals Shift in Public Health Funding Frank Dolan May 2, 2025
HHS Launches $500 Million Universal Vaccine Initiative to Combat Future Pandemics Frank Dolan May 2, 2025
Moderna’s COVID-19 and Flu Vaccine Approval Delayed: What You Need to Know for 2026 Frank Dolan May 2, 2025
Bristol Myers Squibb Shuts Down Chicago Viral Vector Production Site Amid Cost-Cutting Strategy Frank Dolan May 1, 2025
Teladoc Health Expands Mental Health Solutions with UpLift Acquisition for $30 Million Frank Dolan May 1, 2025
Novartis Acquires Regulus Therapeutics for $800M: A Bold Move to Revolutionize ADPKD Treatment Frank Dolan May 1, 2025
Regeneron Faces Legal Challenges: Court Allows DOJ Lawsuit Over Eylea Medicare Fraud to Proceed Frank Dolan April 30, 2025
